References
Aranda R, Sydora BC, McAllister PL, Binder SW, Yang HY, Targan SR, Kronenberg M (1997) Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+ CD45RBhigh T cells to SCID recipients. J Immunol 158: 3464
Asano M, Toda M, Sakaguchi N, Sakaguchi S (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184: 387
Asseman A, Mauze S, Leach M, Coffman R, Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells which inhibit intestinal inflammation. J Exp Med 190 (7): 995
Berg D, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ Th1-like responses. J Clin Invest 98: 1010
Bleijs D, Waal-Malefyt R de, Figdor CG, Kooyk Y van (1999) Co-stimulation of T cells results in distinct IL-10 and TNF-α cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3. Eur J Immunol 29: 2248
Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, Druet P, Pelletier L (1997) Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4+ T cell lines. J Exp Med 185: 1769
Buer J, Lanoue A, Franzke A, Garcia C, Boehmer H von, Sarukhan A (1998) Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 187: 177
Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC (1999) Peptide induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 11: 1625
Chen Y, Kuchroo V, Riche J, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237
Ding L, Shevach EM (1992) IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148: 3133
Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M (1996) Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 26: 934
Elson C, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344
Fiorentino D, Zlotnik A. Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Thl cells. J Immunol 146: 3444
Gonnella P, Chen Y, Inobe J, Komagata Y, Quartulli M, Weiner HL (1998) In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J Immunol 160: 4708
Gran G, Piguet PF, Vassalli P, Lambert PH (1989) Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev 112: 49
Groux H, Bigler M, Vries JE de, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184: 19
Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, Vries JE de, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737
Hagenbaugh A, Sharma S, Dubinett SM, Wei SHY, Aranda R, Cheroutre H, Fowell DJ, Binder S, Tsao B, Locksley RM, Moore KW, Kronenberg M (1997) Altered immune responses in interleukin 10 transgenic mice. J Exp Med 185: 2101
Han H, Jun HS, Utsugi T, Yoon JW (1996) A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 9: 331
Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K (1997) TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol 159: 4484
Khoo U, Proctor IE, Macpherson AJ (1997) CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 158: 3626
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263
Kullberg M, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A (1998)Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 66: 5157
Maeda H, Kuwahara H, Ichimura Y, Ohtsuki M, Kurakata S, Shiraishi A (1995) TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J Immunol 155; 4926
Mason D, Powrie F (1998) Control of immune pathology by regulatory T cells. Curr Opin Immunol 10: 649
Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991
Medzhitov R, Janeway CA (1998) An ancient system of host defense. Curr Opin Immunol 10: 12
Moore K, O'Garra A, Waal Malefyt R de, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165
Morrissey P, Charrier K, Braddy S, Liggitt D, Watson JD (1993) CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178: 237
Nicholson L, Greer JM, Sobel RA, Lees MB, Kuchroo VK (1995) An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3: 397
Papiernik M, Moraes ML de, Pontoux C, Vasseur F, Penit C (1998) Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10: 371
Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5: 1461
Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL (1994) Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553
Powrie F, Leach MW (1995) Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther Immunol 2: 115
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL (1996) A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J Exp Med 183: 2669
Powrie F, Mauze S, Coffman RL (1997) CD4+ T -cells in the regulation of inflammatory responses in the intestine. Res Immunol 148: 576
Read S, Mauze S, Asseman C, Bean A, Coffman R, Powrie F (1998) CD38− CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur J Immunol 28: 3435
Rizzo L, Morawetz RA, Miller-Rivero NE, Choi R, Wiggert B, Chan CC, Morse HC 3rd, Nussenblatt RB, Caspi RR (1999) IL-4 and IL-10 are both required for the induction of oral tolerance. J Immunol 162: 2613
Seddon B, Mason D (1999) Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC− cells and CD4+CD8− thymocytes. J Exp Med 189: 279
Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159: 4772
Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18: 61
Sundstedt A, Hoiden I, Rosendahl T, Kalland N, Rooijen N van, Dohlsten M (1997) Immunoregulatory role of IL-10 during superantigen-induced-hyporesponsiveness in vivo. J Immunol 158: 979
Suri-Payer E, Amar AZ, Thornton AM, Shevach EM (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160: 1212
Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148: 1143
Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itch M, Iwata M, Shimizu J, Sakaguchi S (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10: 1969
Takeuchi M, Alard P, Streilein JW (1998) TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 160: 1589
Thornton A, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287
Van Gool S, Vermeiren J, Rafiq K, Lorr K, Boer M de, Ceuppens JL (1999) Blocking CD40 — CD154 and CD80/CD86 — CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur J Immunol 29: 2367
Wahl S (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180: 1587
Weiner H (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18: 335
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fowler, S., Powrie, F. Control of immune pathology by IL-10-secreting regulatory T cells. Springer Semin Immunopathol 21, 287–294 (1999). https://doi.org/10.1007/BF00812258
Issue Date:
DOI: https://doi.org/10.1007/BF00812258